SCHEMBL14205397

SCHEMBL14205397

COc1cc2c(cc1OC)C(Cc1ccc(-c3ccncc3OC)cc1)N(Cl)CC2

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.54
KDM4E B2RXH2 2/20 0.54
ALDH1A1 P00352 2/20 0.54
HSD17B10 Q99714 2/20 0.54
CYP2D6 P10635 2/20 0.54
MAPK1 P28482 1/20 0.54
ALOX15 P16050 1/20 0.51
HCRTR1 O43613 3/20 0.49
HCRTR2 O43614 3/20 0.49
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
ADRA1B P35368 1/20 0.46
KCNH2 Q12809 1/20 0.46
NR1I2 O75469 1/20 0.44
MAOA P21397 1/20 0.44
PTGS2 P35354 1/20 0.44
OPRK1 P41145 1/20 0.44
SLC6A3 Q01959 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14205220 0.93 LMNA (0.53) LMNAKDM4EALDH1A1HSD17B10CYP2D6
SCHEMBL14205218 0.89 LMNA (0.58) LMNAKDM4EALDH1A1HSD17B10CYP2D6
SCHEMBL14205402 0.86 LMNA (0.57) LMNAKDM4EALDH1A1HSD17B10CYP2D6
SCHEMBL14205403 0.83 LMNA (0.51) LMNAKDM4EALDH1A1HSD17B10CYP2D6
SCHEMBL14205219 0.83 LMNA (0.51) LMNAKDM4EALDH1A1HSD17B10CYP2D6
SCHEMBL14205786 0.82 LMNA (0.49) LMNAKDM4EALDH1A1HSD17B10CYP2D6
SCHEMBL4353043 0.82 LMNA (0.65) LMNAKDM4EALDH1A1HSD17B10CYP2D6
SCHEMBL14178703 0.81 HCRTR1 (0.51) LMNAKDM4EALDH1A1HSD17B10CYP2D6
Hydrochloric Acid SCHEMBL4349771 0.81 LMNA (0.64) LMNAKDM4EALDH1A1HSD17B10CYP2D6
SCHEMBL4344459 0.81 CYP2D6 (0.58) LMNAKDM4EALDH1A1HSD17B10CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008064329-A1 THERAPEUTIC TETRAHYDROISOQUINOLINE-BASED COMPOSITIONS FOR CANCER THERAPY UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2008-05-29 WO disclosed